Tradestie Institutional Equity Comparison Engine
PBE vs PKB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PBE Overall Edge
PBE Captures Institutional Edge (2โ0 Pillars ยท 3โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Invesco Biotechnology & Genome ETF (PBE) driven by superior Momentum & Technical, Options & Structure. Fundamentally, PBE trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus PKB at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, PBE sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against PKB sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
PBE N/M vs PKB N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
PBE
1Y +23.9% vs -8.0% ยท 52W Pos 71% vs 2%
Options & Structure Winner
PBE
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (2nd %ile IV)
PBE
NYSE Arca
Invesco Biotechnology & Genome ETF
Institutional Equity
$96.22
-1.7% 1D
Market Cap
N/A
1M Return
+0.15%
1Y Return
+23.93%
Forward P/E
N/M
Unified AI Score
53.2 / 100
HOLD
Tech 41.0
Fund 44.0
Flow 50.0
Mom 41.1
PKB
NYSE Arca
Invesco Building & Construction ETF
Institutional Equity
$85.02
-1.72% 1D
Market Cap
N/A
1M Return
-2.97%
1Y Return
-8.02%
Forward P/E
N/M
Unified AI Score
44.0 / 100
HOLD
Tech 43.0
Fund 49.0
Flow 50.0
Mom 54.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PBE +23.93%
PKB -8.02%
Spread: +31.95 pp (PBE Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
PBE TTM Op. Margin: N/A
PKB TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PBE vs PKB. Trailing 12-month operating profitability (PBE N/A vs PKB N/A) and valuation multiples (PBE N/M vs PKB N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PBE | PKB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 71% ($76โ$105) | 2% ($84โ$116) | Stronger Trend | PBE |
| Beta / 30D Volatility Risk Regime | 0.74ฮฒ ยท 28% Vol | 1.32ฮฒ ยท 35% Vol | Lower Realized Risk | PBE |
| Unified Institutional Score Composite Signal | 53.2 / 100 (HOLD) | 44.0 / 100 (HOLD) | Higher Composite | PBE |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PBE vs PKB Buy Guide
PBE
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
PKB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
2nd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PBE nor PKB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.